Herbal medicine for relapse and metastasis in patients operated for colorectal cancer

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2006, Pages

  Wu, Yu ^a   Luo, L ^b   Liu, J P ^b   Yang, Y F ^b   Guo, Z N ^b  

^a XIYUAN HOSPITAL   (China)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; HERBACEOUS AGENT;

CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; COLORECTAL CANCER; COLORECTAL SURGERY; HERBAL MEDICINE; HUMAN; METASTASIS; POSTOPERATIVE PERIOD; QUALITY OF LIFE; REVIEW; SURVIVAL TIME; TREATMENT OUTCOME;

EID: 37649029597     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006270     Document Type: Review

References (14)

1. Abulafi AM, Williams NS. Local recurrence of colorectal cancer: the problem, mechanisms, management and adjuvant therapy. British Journal Surgery 1994;81(1):7-19.
2. Bao SZ, Sun ZD. Chinese compound recipe Sangen decoction combined with chemotherapy in treating 120 mid- and late stage colorectal cancer patients. Liaoning Journal of Traditional Chinese Medicine 1992;19(7):31.
3. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide. International Agency Research on Cancer Cancer Base no. 5, version 2.0. Lyon: International Agency Research on Cancer Press, 2004.
4. Gill S, Loprinzi CL, Sargent DJ, Thome SD, Alberts SR, Haller DG, Benedetti J, Francini G, Shepherd LE, Francois Seitz J, Labianca R, Chen W, Cha SS, Heldebrant MP, Goldberg RM. Pooled analysis of uorouracil-based adjuvant therapy for stage II and III colon cancer: Who benefits and by how much?. Journal of Clinical Oncology 2004; 22:1797-806.
5. Greene FL, Balch CM, Fleming ID, et al. American Joint Committee on Cancer cancer staging handbook. 6. New York: Springer Verlag, 2002.
6. Guo ZX. Fuzheng Anticancer Prescription in postoperative Treatment for Colorectal Cancer. Chinese Journal of Integrated Traditional and Western Medicine 1999;5(1):10-13.
7. Jemal A, Murray T, Ward E, et al. Cancer statistics 2005. Cancer Journal for Clinicians 2005;55:10-30.
8. Peiwen Li. Postoperative Therapy of Malignant Tumor. 1. Beijing: People's Medical Publishing House, 2002.
9. Mamounas E, Wieand S, Wolmark N, et al. Comparative efficacy of adjuvant chemotherapy in patients with Dukes B versus Dukes C colon cancer: results from fourNational Surgical Adjuvant Breast and Bowel Project adjuvant studies (C-01, C-02, C-03,and C-04). Journal of Clinical Oncology 1999;17:1349- 55.
10. Meyerhardt JA, Mayer RJ. Systemic therapy for colorectal cancer. New England Journal of Medicine 2005;352(5):476-487.
11. Nanjing University of traditional Chinese Medicine. Translation and interpretation for Huang Di Nei Jing Su Wen. 3. Shanghai Press of Science, Technology and Medicine, 1996.
12. Pan MQ, Pan B, Li YH. Clinical Observation on Yiqitiaofu Decoction Combined Chemical Therapy for the Treatment of 43 Cases of Large Intestine Cancer. Hunan Guiding Jounal of Traditional Chinese Medicine and Pharmacology 2003;9(11):12-4.
13. National Office of Treatment and Research for Tumor, Centre of Ministry of Health for Healthy and Statistics Data. Monitoring Incidence and Death of malignant Tumor in City and County of China. Vol. 12, Beijing: China Press of Science, Technology and Medicine, 2002.
14. Shen HC, Zhu XR, Luo SM. Clinical Study on the Effect of Changbi'an Capsules on the Postoperative Prognosis of Colorectal Carcinoma. Zhejiang Jounal of Traditional Chinese Medicine Combined with Western Medicine 2003;13(10):600-1.